Future Of Drug Safety Evaluation: Innovations And Challenges
Received Date: Oct 01, 2025 / Published Date: Oct 29, 2025
Abstract
Thisbodyofworkexaminescontemporaryapproachestodrugsafetyevaluation, encompassingclinicaltrials, post-marketsurveil
lance, and novel therapeutic modalities. It highlights the increasing integration of real-world data, artificial intelligence, and pharma
cogenomics to enhance safety assessments and personalize medicine. Challenges in evaluating new drug delivery systems, biologics,
and digital therapeutics are discussed, alongside the critical role of ethical considerations and global regulatory harmonization. The
research underscores the dynamic and evolving nature of drug safety science.
Citation: 脗聽Khalid DH (2025) Future Of Drug Safety Evaluation: Innovations And Challenges. Int J Res Dev Pharm L Sci 11: 299.
Copyright: 漏 2025 Dr. Hanan Khalid This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted聽use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 366
- [From(publication date): 0-0 - Apr 04, 2026]
- Breakdown by view type
- HTML page views: 319
- PDF downloads: 47
